Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy

[1]  Huile Gao,et al.  Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors , 2021, Acta pharmaceutica Sinica. B.

[2]  Jianliang Shen,et al.  Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy. , 2021, Carbohydrate polymers.

[3]  F. Dai,et al.  Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy , 2021, Acta pharmaceutica Sinica. B.

[4]  Heebeom Koo,et al.  Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles , 2021, Bioactive materials.

[5]  Yaping Li,et al.  Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer , 2021, Acta pharmaceutica Sinica. B.

[6]  Dunwan Zhu,et al.  Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle , 2021, Acta pharmaceutica Sinica. B.

[7]  Xiao-xiao Qi,et al.  Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice , 2021, Acta Pharmacologica Sinica.

[8]  Jianliang Shen,et al.  Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy , 2021, Journal of Nanobiotechnology.

[9]  Y. Lou,et al.  Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy , 2021, Journal of Nanobiotechnology.

[10]  Xiaoming Li,et al.  Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal , 2021, Journal of Nanobiotechnology.

[11]  Ying Zhang,et al.  Tumor vasculature-targeting nanomedicines. , 2021, Acta biomaterialia.

[12]  Xiaolong Liu,et al.  Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy , 2021, Journal of Nanobiotechnology.

[13]  Chen Chen,et al.  A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving , 2021, Acta pharmaceutica Sinica. B.

[14]  Xuesi Chen,et al.  Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101 , 2021, Theranostics.

[15]  J. Sun,et al.  Pure photosensitizer-driven nanoassembly with core-matched PEGylation for imaging-guided photodynamic therapy , 2021, Acta Pharmaceutica Sinica. B.

[16]  Jinsong Ding,et al.  A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances , 2021, Journal of Nanobiotechnology.

[17]  L. Qi,et al.  Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. , 2021, ACS applied materials & interfaces.

[18]  Yongxue Zhang,et al.  Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer , 2021, Journal of Nanobiotechnology.

[19]  Huile Gao,et al.  Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer , 2021, Advanced Functional Materials.

[20]  Shenglin Luo,et al.  Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy , 2021, Science Advances.

[21]  Jingwei Shao,et al.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy , 2020, Asian journal of pharmaceutical sciences.

[22]  E. Song,et al.  LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer , 2020, Nature Communications.

[23]  Yunching Chen,et al.  Nanoparticle Delivery of MnO2 and Anti-angiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma. , 2020, ACS applied materials & interfaces.

[24]  M. Yin,et al.  Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5 , 2020, Acta pharmaceutica Sinica. B.

[25]  Jun Xu,et al.  Photosensitizer-Modified MnO2 Nanoparticles to Enhance Photodynamic Treatment of Abscesses and Boost Immune Protection for Treated Mice. , 2020, Small.

[26]  Huifang Zhou,et al.  Fluorinated-functionalized hyaluronic acid nanoparticles for enhanced photodynamic therapy of ocular choroidal melanoma by ameliorating hypoxia. , 2020, Carbohydrate polymers.

[27]  Jee‐Heon Jeong,et al.  Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Yibin Wang,et al.  Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. , 2020, Cell metabolism.

[29]  Ji Hyeon Kim,et al.  Unimolecular Photodynamic O2-Economizer to Overcome Hypoxia Resistance in Phototherapeutics. , 2020, Journal of the American Chemical Society.

[30]  Yong Hu,et al.  Hybrid nanoparticle composites applied to photodynamic therapy: strategies and applications. , 2020, Journal of materials chemistry. B.

[31]  Houhe Liu,et al.  Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy. , 2020, Nano letters.

[32]  Z. Zeng,et al.  Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy , 2020, Molecular Cancer.

[33]  Dongyang Zhao,et al.  Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development , 2020, Acta pharmaceutica Sinica. B.

[34]  C. Yeh,et al.  Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound , 2019, Theranostics.

[35]  Peipei Xu,et al.  Overcoming Hypoxia by Multistage Nanoparticle Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy , 2019, Advanced Functional Materials.

[36]  Suping Li,et al.  Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature. , 2018, Molecular pharmaceutics.

[37]  Xin-hua Liang,et al.  Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy , 2018, OncoTargets and therapy.

[38]  Ligeng Xu,et al.  Photosensitizer-crosslinked in-situ polymerization on catalase for tumor hypoxia modulation & enhanced photodynamic therapy. , 2018, Biomaterials.

[39]  Juyoung Yoon,et al.  Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy. , 2018, Angewandte Chemie.

[40]  W. Symmans,et al.  Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. , 2018, Molecular cell.

[41]  M. Odenthal,et al.  Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. , 2018, Cancer research.

[42]  Jing Yan,et al.  Targeting VEGF/VEGFR to Modulate Antitumor Immunity , 2018, Front. Immunol..

[43]  D. Hanahan,et al.  Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma , 2017, Science Translational Medicine.

[44]  F. Ross,et al.  Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib , 2017, Cell chemical biology.

[45]  D. Hanahan,et al.  Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation , 2017, Science Translational Medicine.

[46]  Y. Kienast,et al.  Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade , 2017, Science Translational Medicine.

[47]  Wei Li,et al.  Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis. , 2014, Biomaterials.

[48]  V. Grégoire,et al.  Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[49]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[50]  Timothy W Secomb,et al.  Synergistic effects of hyperoxic gas breathing and reduced oxygen consumption on tumor oxygenation: a theoretical model. , 2004, International journal of radiation oncology, biology, physics.